Three-dimensional exergaming conjunction with vestibular rehabilitation in individuals with Benign Paroxysmal Positional Vertigo: A feasibility randomized controlled study


Ozdil A., Iyigun G., BALCI B.

Medicine (United States), cilt.103, sa.27, 2024 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 103 Sayı: 27
  • Basım Tarihi: 2024
  • Doi Numarası: 10.1097/md.0000000000038739
  • Dergi Adı: Medicine (United States)
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, CINAHL, Veterinary Science Database, Directory of Open Access Journals
  • Anahtar Kelimeler: balance, benign paroxysmal positional vertigo, dizziness, gait, vestibular rehabilitation, virtual reality
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Background: To examine the effectiveness of 3D (dimensional)-vestibular rehabilitation therapy (VRT) on gait, balance problems, processing time speed and subjective complaints in patients with Benign Paroxysmal Positional Vertigo (BPPV) compared to a control group (CG). This study aimed to test the feasibility of virtual reality-based 3D exergaming conjunction with vestibular rehabilitation. Methods: Twenty-two patients with BPPV (negative DixHallpike/Roll test results, existing dizziness/balance complaints) were randomly allocated to the study group (SG, n:11 3D-VRT) or Control group (CG n:11, no exercise-rehabilitation) for 8 week. The SG performed 3D-VRT for 45 to 50 min/d, 3 times/wk, and the CG did receive only Canalith Repositioning Maneuver (CRM). CRM was applied in both groups before the study. Outcome measures included 10-Meter-Walk-Test (10-MWT) (with/without head turns), Dynamic Gait Index (DGI), Choice-Stepping-Reaction-Time-ped (CSRT-MAT), Fullerton Advanced Balance Scale (FAB), and Visual Analog Scale (VAS). Results: The SG showed significantly improvement in 10-MWT without (p5 = 0.00, η2 = 0.49), with horizontal (p5 = 0.00, η2 = 0.57), vertical (p5 = 0.01, η2 = 0.48) head turns, DGI (p5 = 0.00, η2 = 0.74), CSRT-MAT, FAB (p5 = 0.00, η2 = 0.78) and VAS-dizziness (p5 = 0.00, η2 = 0.65), VAS-balance problem (p5 = 0.00, η2 = 0.43), VAS-fear of falling (p5 = 0.00, η2 = 0.42) compared to the CG. Conclusion: The 3D-VRT were effective in improving gait, balance, processing speed and resolving the subjective complaints in BPPV. The 3D-VRT method is feasible for patients who suffer from residual dizziness or balance complaints after CRM. Furthermore, the 3D-VRT is more accessible and less expensive than other virtual reality applications, which may facilitate further research or clinical use.